Manager, Commercial Strategy Analytics

The role

This person will support the early commercial strategy team through competitive intelligence, market research, and forecasting analysis. They will synthesize and communicate strategic insights to support pre-commercial strategy.

What you will do

• Support development of asset-level and portfolio-level pre-commercial or commercial readiness analyses.
• Conduct market sizing, epidemiology, competitive landscape, and pricing & reimbursement analyses.
• Build and maintain revenue forecast models.
• Support continued development of existing initiatives across the corporate strategy team.
• Gather and capture market data to support data-driven analyses.
• Communicate findings in an efficient manner.

Required qualifications

• Bachelor’s degree in a life sciences discipline
• 5+ years of relevant experience
• Direct experience synthesizing and communicating competitive insights from drug development programs and/or companies
• Exceptional analytical skills
• Broad understanding of the life sciences business and R&D process
• Excellent communication skills engaging with external experts and internal stakeholders
• Experience building and interpreting financial models
• Familiarity with the rare disease space
• Ability to be a team player with a can-do attitude

Nice to have

• PhD
• MBA
• Other advanced degree
• Experience in an analytical role such as market research, equity research, life sciences consulting, commercial analytics, or prior experience in biotech/pharma

Benefits

• Health, dental and vision coverage
• Life and disability insurance
• 401(k) match
• Paid, gender-inclusive parental leave
• Holistic support for health and well-being
• Education reimbursement
• Discretionary time off
• Commuting benefits

About the company

Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets. They are advancing a development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases.